How rare is diffuse scleroderma?
Approximately one in 10,000 individuals is affected. It is more common in women and most often develops around age 30 to 50. Systemic scleroderma can affect almost any organ in the body, and there is a large variability of symptoms among affected individuals.
How many people have diffuse scleroderma?
Who develops scleroderma, and when? It’s estimated that about 300,000 Americans have scleroderma. About one third of those people have the systemic form of scleroderma. Since scleroderma presents with symptoms similar to other autoimmune diseases, diagnosis is difficult.
Who is most affected by scleroderma?
Scleroderma (sklair-oh-DUR-muh) is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Scleroderma affects women more often than men and most commonly occurs between the ages of 30 and 50.
Is diffuse scleroderma hereditary?
Genetics plays a role in the disease, but it is not passed on from parents to children, and it’s rare for immediate family members of those with scleroderma to get it. It is common for family members, however, to have other autoimmune diseases such as thyroid disease, rheumatoid arthritis or lupus.
What percentage of the population has scleroderma?
Scleroderma affects about 300,000 people in the United States, about one in every thousand. The number of people affected worldwide is unknown, but the disease has been reported all across the globe.
Is limited scleroderma a rare disease?
Scleroderma is a rare autoimmune connective tissue disorder characterized by abnormal thickening of the skin. Connective tissue is composed of collagen, which supports and binds other body tissues. There are several types of scleroderma.
How long can you live with diffuse scleroderma?
Patients with diffuse cutaneous systemic sclerosis have a 10-year survival estimate of approximately 75%. However, development of ILD, PAH, or renal crisis dramatically increases the risk of death.
How many people a year are diagnosed with scleroderma?
This form of scleroderma can occur at any age but is most common in women of childbearing age. It occurs in around 30 persons per million population per year and there are an estimated 125,000 active cases in the United States and perhaps 2.5 million worldwide.
What is the life expectancy of people with scleroderma?
People who have localized scleroderma may live an uninterrupted life with only minor symptom experiences and management. On the other hand, those diagnosed with an advanced and systemic version of the disease have a prognosis of anywhere from three to 15 years.
What is the prevalence of diffuse scleroderma?
About 35 percent of patients with systemic scleroderma develop the diffuse form of the disease. The tightening of the skin may make it difficult for patients to bend their fingers, a condition known as sclerodactyly, as well as their hands and other joints.
What are the different types of systemic scleroderma?
Within the systemic forms of scleroderma, there are three major categories of the disease: diffuse, limited and overlap syndromes. The more rapidly progressing forms of systemic scleroderma are in a category called diffuse scleroderma.
Is there a cure for diffuse systemic scleroderma?
There is no cure, so far, for diffuse systemic scleroderma, but treatments are available to ease symptoms, to prevent the worsening of the disease, and to improve patients’ overall quality of life. Treatment regimens may differ between individuals depending on the organs that are affected.
Does everyone with scleroderma develop skin changes?
Scleroderma (literally “hard skin”) is an umbrella term for a family of rare diseases with the common factor being abnormal thickening (fibrosis) of the skin. However, not everyone with scleroderma develops skin changes. With some variants of the disease, skin changes usually occur early in the disease process and can develop very rapidly.